Brain injury markers found in the blood months after COVID-19 infection

A new study published today (22 December 2023) in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal.

Researchers uncover the incidence and prevalence of eosinophilic esophagitis in Japan

In one of the first studies of its kind in Japan, Osaka Metropolitan University-led researchers uncovered the incidence and prevalence of the chronic allergic disorder

July 10, 2024

Effectiveness of Lactobacillus in treating inflammatory bowel disease

The role of Lactobacillus in treating inflammatory bowel disease.

October 4, 2023

Pfizer’s first-ever bispecific antibody Elrexfio holds promise in multiple myeloma

Elrexfio’s higher dosage and limited trials may hinder its ability to rival Tecvayli. Credit: Kateryna Kon via Shutterstock. The US Food and Drug Administration’s recent

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.